Further processing options
Epigallocatechin gallate (EGCG) suppresses growth and tumorigenicity in breast cancer cells by downregulation of miR-25
Saved in:
Journal Title: | Bioengineered |
---|---|
Authors and Corporations: | , , , |
In: | Bioengineered, 10, 2019, 1, p. 374-382 |
Type of Resource: | E-Article |
Language: | English |
published: |
Informa UK Limited
|
Subjects: |